INS and obesity due to melanocortin 4 receptor deficiency: GLP-1 has demonstrated its efficacy in treating diabetes and obesity by utilizing multiple mechanisms, including stimulating insulin secretion, inhibiting glucagon secretion, protecting β cells and decreasing food intake.